Skip to main content
. 2020 May 5;72(3):202–204. doi: 10.1016/j.ihj.2020.04.008

Table 1.

Prevalence of cardiometabolic risk factors according to Waist Circumference.

Risk Factors Group I
Group II
Group III
WC in M < 80 or F < 70 cm WC in M80-89 cm or F70-79 cm WC in M ≥ 90or F ≥ 80 cm
Gender wise prevalence Male (n = 156) Female (n = 97) Total (n = 253) Male (n = 187) Female (n = 162) Total (n = 349) Male (n = 247) Female (n = 329) Total (n = 576)
Impaired fasting glucose 13(8.3) 7(7.2) 20(7.9) 36(19.3)∗ 20(12.3) 56(16.0)∗ 69(27.9)†‡ 77(23.4)†‡ 146(25.3)†‡
Impaired glucose tolerance 8(5.1) 6(6.2) 14(5.5) 28(15.0)∗ 12(7.4) 40(11.5)∗ 68(27.5)†‡ 70(21.3)†‡ 138(24.0)†‡
Diabetes 11(7.1) 2(2.1) 13(5.1) 27(14.4)∗ 7(4.3) 34(9.7)∗ 67(27.1)†‡ 71(21.6)†‡ 138(24.0)†‡
Hypertension 37(23.7) 13(13.4) 50(19.8) 52(27.8) 39(24.1)∗ 91(26.1) 138(55.9) †‡ 152(46.2)†‡ 290(50.3)†‡
Metabolic Syndrome 12(7.7) 9(9.3) 21(8.3) 25(13.4) 36(22.2)∗ 61(17.5)∗ 165(66.8) †‡ 262(79.6)†‡ 427(74.1)†‡
Hypercholesterolaemia 20 (12.8) 16 (16.5) 36 (14.2) 36 (19.3) 38 (23.5) 74 (21.2)∗ 72 (29.1) †‡ 91 (27.7) † 163 (28.3) †‡
Hypertriglyceridaemia 32 (20.5) 16 (16.5) 48 (19.0) 66 (35.3)∗ 44 (27.2) 110 (31.5)∗ 134 (54.3) †‡ 152 (46.2) †‡ 286 (49.7) †‡
Increased LDL 37 (23.7) 21 (21.6) 58 (22.9) 39 (20.9) 47 (29.0) 86 (24.6) 51 (20.6) 70 (21.3) 121 (21.0)
Low HDL cholesterol 13 (8.3) 76 (78.4) 89 (35.2) 17 (9.1) 134 (82.7) 151 (43.3) 26 (10.5) 287 (87.2) † 313 (54.3) †‡

Values are shown as no (%),∗Group I versus II; statistical significance at the p < 0.05 level.

†Group I versus III; all statistical significant (p < 0.05); ‡Group II versus III statistical significance (p < 0.05).